XSS in Bdtask G-Prescription Gynaecology \& Obs Consultation
CVE-2024-2274
A vulnerability, which was classified as problematic, has been found in Bdtask G-Prescription Gynaecology & OBS Consultation Software 1.0. This issue affects some unknown processing of the file /Home/Index of the component Prescription Dashboard. The manipulation of the argument Title leads to cross site scripting. The attack may be initiated remotely. The exploit has been disclosed to the public and may be used. The associated identifier of this vulnerability is VDB-256043. NOTE: The vendor was contacted early about this disclosure but did not respond in any way.
Vulnerability class: XSS (Cross-Site Scripting)
EPSS: 0.005 (39.2th percentile) — read the EPSS interpretation.
CVSS v3 metric
CVSS v3 base score 2.4 (Low). Vector: CVSS:3.1/AV:N/AC:L/PR:H/UI:R/S:U/C:N/I:L/A:N.
Affected products
- Bdtask G-prescription_gynaecology_\&_obs_consultation — versions 1.0
- Bdtask G-prescription Gynaecology & Obs Consultation Software — versions 1.0
Weakness classification (CWE)
Public proof-of-concept exploits
References
- cna@vuldb.com (Permissions Required, technical-description, vdb-entry)
- cna@vuldb.com (signature, Permissions Required, permissions-required)
- cna@vuldb.com (Exploit, exploit)
Frequently asked questions
- What is CVE-2024-2274?
- CVE-2024-2274 is a low-severity vulnerability in Bdtask G-Prescription Gynaecology \& Obs Consultation, classified under Cross-site Scripting. CVSS score: 2.4/10. Published 2024-03-08.
- How severe is CVE-2024-2274?
- Low severity. CVSS v3 base score is 2.4 out of 10.
- Is CVE-2024-2274 known to be exploited?
- 2 public proof-of-concept repositories are indexed. Not currently listed in the CISA KEV catalog.